Advertisement
Commentary| Volume 60, ISSUE 12, P1304-1305, December 15, 2006

The Vascular Depression Hypothesis: 10 Years Later

      The vascular depression hypothesis was formulated in 1997 and postulated that cerebrovascular disease can predispose, precipitate, or perpetuate a depressive syndrome in older adults. The term “vascular depression” encompassed entities with diverse pathogenetic mechanisms. The original article argued that “direct testing of the vascular depression hypothesis is not possible since the mechanisms of depression are unknown” (
      • Alexopoulos G.S.
      • Meyers B.S.
      • Young R.C.
      • Campbell S.
      • Silbersweig D.
      • Charlson M.
      The “vascular depression” hypothesis.
      ). The hypothesis was viewed, however, as the intellectual platform for studies of the clinical presentation, outcomes, pathogenesis, and treatment of a subgroup of geriatric individuals with depression.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Alexopoulos G.S.
        The depression–executive dysfunction syndrome of late life: A specific target for D3 receptor agonists?.
        Am J Geriatr Psychiatry. 2001; 9: 1-8
        • Alexopoulos G.S.
        Depression in the elderly.
        Lancet. 2005; 365: 1961-1970
        • Alexopoulos G.S.
        • Kiosses D.N.
        • Choi S.J.
        • Murphy C.F.
        • Lim K.O.
        Frontal white matter microstructure and treatment response of late-life depression: A preliminary study.
        Am J Psychiatry. 2002; 159: 1929-1932
        • Alexopoulos G.S.
        • Kiosses N.
        • Heo M.
        • Murphy C.F.
        • Shanmugham B.
        • Gunning-Dixon F.
        Executive dysfunction and the course of geriatric depression.
        Biol Psychiatry. 2005; 58: 204-210
        • Alexopoulos G.S.
        • Kiosses D.N.
        • Klimstra S.
        • Kalayam B.
        • Bruce M.L.
        Clinical presentation of the “depression-executive dysfunction syndrome” of late life.
        Am J Geriatr Psychiatry. 2002; 10: 98-102
        • Alexopoulos G.S.
        • Meyers B.S.
        • Young R.C.
        • Campbell S.
        • Silbersweig D.
        • Charlson M.
        The “vascular depression” hypothesis.
        Arch Gen Psychiatry. 1997; 54: 915-922
        • Krishnan K.R.R.
        Psychiatric disease in the genomic era: A rational approach.
        Mol Psychiatry. 2005; 10: 978-984
        • Krishnan K.R.R.
        • Taylor W.D.
        • McQuaid D.R.E.
        • MacFall J.R.
        • Payne M.E.
        • Provenzale J.M.
        • Steffens D.C.
        Clinical characteristics of magnetic resonance imaging–defined subcortical ischemic depression.
        Biol Psychiatry. 2004; 55: 390-397
        • Potter G.D.
        • Kittinger J.D.
        • Wagner H.R.
        • Steffens D.C.
        • Krishnan K.R.R.
        Prefrontal neuropsychological predictors of treatment remission in late-life depression.
        Neuropsychopharmacology. 2004; 29: 2266-2271
        • Salloway S.
        • Boyle P.A.
        • Correia S.
        • Malloy P.F.
        • Cahn-Weiner D.A.
        • Schneider L.
        • et al.
        The relationship of MRI subcortical hyperintensities to treatment response in a trial of sertraline in geriatric depressed outpatients.
        Am J Geriatr Psychiatry. 2002; 10: 107-111